1. Home
  2. OOMA vs STRO Comparison

OOMA vs STRO Comparison

Compare OOMA & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ooma Inc.

OOMA

Ooma Inc.

N/A

Current Price

$20.80

Market Cap

565.7M

Sector

Technology

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

N/A

Current Price

$15.93

Market Cap

332.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OOMA
STRO
Founded
2003
2003
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
565.7M
332.8M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
OOMA
STRO
Price
$20.80
$15.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
14
Target Price
$26.60
★ $47.23
AVG Volume (30 Days)
★ 391.3K
284.8K
Earning Date
08-26-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 188.46
N/A
EPS
★ 0.20
N/A
Revenue
★ $114,490,000.00
$38,419,000.00
Revenue This Year
$21.68
N/A
Revenue Next Year
$4.82
N/A
P/E Ratio
$106.70
★ N/A
Revenue Growth
★ 9.53
N/A
52 Week Low
$9.79
$0.72
52 Week High
$26.19
$43.85

Technical Indicators

Market Signals
Indicator
OOMA
STRO
Relative Strength Index (RSI) 35.47 31.62
Support Level $19.66 $14.81
Resistance Level $21.57 $17.33
Average True Range (ATR) 0.80 0.92
MACD -0.31 0.21
Stochastic Oscillator 0.65 44.34

Price Performance

Historical Comparison
OOMA
STRO

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that delivers voice and collaboration features, including messaging, intelligent virtual attendants, and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: